NCT00983047 2015-08-27Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung CancerBiotech Pharmaceutical Co., Ltd.Phase 2 Terminated30 enrolled
NCT00161278 2008-07-30Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression ProfilingUniversity of Michigan Rogel Cancer CenterPhase 2 Terminated1 enrolled